Brief: Enorama Pharma Postpones Publication Of 2025 Report Due To Control Balance Sheet
10/03/2026 10:19
March 10 (Reuters) - Enorama Pharma AB ERMA.ST: POSTPONES PUBLICATION OF 2025 REPORT TO MARCH 18, 2026 DUE TO PREPARATION OF CONTROL BALANCE SHEET Source text: ID:nWkrc47xtg Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO